Nekton Capital Ltd. Horizon Therapeutics Public LTD CO Transaction History

Nekton Capital Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $21.6 Million - $25.1 Million	-223,740 Reduced 43.21%	294,015 $30.2 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $26.5 Million - $28 Million	246,840 Added 91.11%	517,755 $56.5 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $16.9 Million - $30.8 Million	270,915 New	270,915 $30.8 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $7.05 Million - $10.3 Million	88,845 New	88,845 $7.09 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nekton Capital Ltd., based on Form 13F filings with the SEC.

Stay updated on Nekton Capital Ltd. with notifications on news.